---
$id: https://graph.org.ai/products/commodity/51151668
$type: Product
source: UNSPSC
code: "51151668"
title: "Trimebutine"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trimebutine

**UNSPSC Code**: 51151668
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C22H29NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QZ1OJ92E5R, chemically known as 3,4,5-trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester but generally known as trimebutine, which bears US NIH Compound Identifier 5573. European Medicines Agency schedules Trimebutine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11299MIG. The term TRIMEBUTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules trimebutine in its Anatomical Therapeutic Chemical (ATC) Classification. TRIMEBUTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trimebutine under HS 29221980 and SITC 51461. As of Q4 2014, TRIMEBUTINE remains the US FDA Preferred Term for this commodity. Trimebutine bears US NLM identifiers UMLS ID C0041023 and NCI Concept Code C80588. SMILES: O(CC(N(C)C)(CC)C1CCCCC1)C(=O)C1CC(OC)C(OC)C(OC)C1.

